Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer--A Retrospective Cohort Study [FOCUS ON QUALITY]

Conclusion: Most female patients with stage I to III breast cancer in Vermont are receiving adjuvant chemotherapy within the National Comprehensive Cancer Network–recommended timeframe; however, improvements remain needed for certain subgroups. Novel approaches for women with long drive times need to be developed and evaluated in the community. Variation in TTC by hospital, even after adjusting for patient, tumor, and treatment factors, also suggests opportunities for process improvement.
Source: Journal of Oncology Practice - Category: Cancer & Oncology Authors: Tags: Quality of care, Access to care, Access to care, Management and treatment, Epidemiology, Chemotherapy, Population and Observational Studies, Quality of Care, Epidemiology FOCUS ON QUALITY Source Type: research